[Acute decompensation in chronic respiratory failure. Our current therapeutic management].
D000667:Ampicillin / Q000627:therapeutic use; D001623:Betamethasone / Q000627:therapeutic use; D001945:Breathing Exercises; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004315:Doxapram / Q000627:therapeutic use; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000627:therapeutic use*; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000628:therapy*; D012151:Resuscitation
D000697:Central Nervous System Stimulants; D004232:Diuretics; D009025:Morpholines; D011760:Pyrrolidinones; D002701:Chloramphenicol; D000667:Ampicillin; D004315:Doxapram; D001623:Betamethasone; D008775:Methylprednisolone
Decompensations aigues des insuffisances respiratoires chroniques. Notre conduite thérapeutique actuelle.